Connecting the dots: Network structures of internalizing and functional symptoms in a population-based cohort.
Saini, Urvi, Rosmalen, Judith G M, Oldehinkel, Albertine J et al. · Journal of psychosomatic research · 2024 · DOI
Quick Summary
This study looked at how symptoms of depression, anxiety, ME/CFS, fibromyalgia, and irritable bowel syndrome are connected in over 70,000 people. Researchers found that these conditions tend to cluster separately, but are linked together through specific 'bridge' symptoms like fatigue, difficulty concentrating, and sleep problems. This helps explain why people often experience multiple conditions at the same time.
Why It Matters
This research provides evidence that ME/CFS symptoms—particularly fatigue and cognitive difficulties—are key connectors between psychiatric and functional somatic conditions, suggesting shared biological mechanisms. Understanding these symptom bridges may help clinicians recognize and treat underlying causes rather than treating conditions in isolation, potentially improving outcomes for ME/CFS patients with comorbid mood or anxiety disorders.
Observed Findings
Fatigue was associated with 86.6% of other symptoms across both internalizing and functional domains.
Difficulty concentrating was connected to 78.9% of symptoms, the second-strongest bridge symptom.
Trouble sleeping and unrefreshing sleep were identified as key bridge symptoms linking the two domains.
Internalizing disorder and functional disorder symptoms clustered within their respective domains but remained moderately interconnected overall (52.7% network density).
No significant differences in network structure or connectivity were found between males and females or between younger and older adults.
Inferred Conclusions
Bridge symptoms like fatigue and cognitive difficulty may represent central mechanisms underlying the comorbidity between internalizing and functional somatic disorders.
Symptom-level networks reveal moderate but distinct connectivity between psychiatric and functional domains, suggesting both separate and shared pathways.
The consistency of network structure across sex and age groups suggests these symptom relationships are robust features of the conditions themselves rather than demographic artifacts.
Remaining Questions
What biological mechanisms (immune, mitochondrial, autonomic, neuroinflammatory) underlie these symptom bridge connections?
What This Study Does Not Prove
This study cannot establish causation or determine whether bridge symptoms cause comorbidity or merely reflect it. The cross-sectional design means we cannot determine the temporal sequence of symptom development. The findings also do not explain the biological mechanisms underlying these symptom connections.